Revolutionizing Biopharma manufacturing
LenioBio develops efficient and sustainable technologies for protein expression. Company with a clear goal: To simplify protein production and accelerate the delivery of drugs to patients.
Revolutionizing Biopharma manufacturing LenioBio develops efficient and sustainable technologies for protein expression. Company with a clear goal: To simplify protein production and accelerate the delivery of drugs to patients. emberto Martis first came across the cell-free protein expression technology developed by Corteva Agriscience and Fraunhofer IME while working as a business developer for Fraunhofer IME. He quickly realized that this technology could have a lasting impact on the pharmaceutical and food industries, as well as other sectors, once it was scaled. In 2016, he founded LenioBio as a biotechnology company specializing in protein expression solutions. Today, the Düsseldorf-based company employs more than 40 scientists and business experts. Besides producing proteins on demand at any location, LenioBio reduces the time required to develop and market the medications. “With the belief that every person deserves an equal chance to lead a healthy life and that this begins with access to LenioBio’s Leadership Team (LTR): Remberto Martis, Franziska Finke and Ricarda Finnern effective and affordable medicines wherever they are needed, we apply nature for better science,” emphasizes Franziska Finke, CFO at LenioBio.
-
Most popular related searches
Customer comments
No comments were found for Revolutionizing Biopharma manufacturing. Be the first to comment!